About the Macular Degeneration Session
Macular degeneration is a progressive eye condition affecting the central part of the retina, known as the macula. This area is crucial for sharp, central vision needed for activities like reading and driving. There are two types: dry macular degeneration, characterized by the gradual thinning of the macular tissue, and wet macular degeneration, marked by abnormal blood vessel growth under the retina.
Risk factors include aging, genetics, smoking, and prolonged sun exposure. Symptoms may include blurry or distorted central vision, straight lines appearing wavy, and difficulty recognizing faces. While there is no cure, early detection through regular eye exams is crucial for managing the condition and preventing severe vision loss. Treatment options vary depending on the type and severity, ranging from dietary supplements and lifestyle changes to injections or laser therapy for wet macular degeneration. Ongoing research aims to develop more effective therapies to preserve vision and improve quality of life for those affected.
Topics Covered in Macular Degeneration
Dry AMD & Geographic Atrophy
Neovascular Wet AMD
Drusen
Anti-VEGF Therapy
Amsler Grid Monitoring
Genetic & Smoking Risk Factors
Related Scientific Sessions at IOC 2027
Why Attend the Macular Degeneration Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Macular Degeneration work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Macular Degeneration research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Macular Degeneration track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Macular Degeneration Conference 2027 — FAQs
What is the Macular Degeneration track at IOC 2027?
The Macular Degeneration track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Macular Degeneration. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Macular Degeneration sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Macular Degeneration are all welcome — whether presenting or attending.
Can I present my research in the Macular Degeneration track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Macular Degeneration sessions?
Yes. IOC 2027 is a hybrid conference — attend the Macular Degeneration track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
